<DOC>
	<DOCNO>NCT01486914</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial compare insulin aspart produce current process NN2000 process .</brief_summary>
	<brief_title>Comparison Insulin Aspart Produced Current Process NN2000 Process</brief_title>
	<detailed_description />
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<criteria>Healthy Caucasian Normal finding medical history physical examination unless investigator considers abnormality clinically irrelevant Fasting blood glucose equal 6 mmol/L Body mass index ( BMI ) 22.027.0 kg/m^2 ( inclusive ) Participated another clinical study investigational drug within last 4 week Any condition require regular use medication , include herbal remedy , counter medicine vitamin . Occasional paracetamol acceptable Known suspect allergy trial product relate product Family history type 2 diabetes</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>